Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Times Interest Earned (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Times Interest Earned for 16 consecutive years, with -$1.3 as the latest value for Q4 2025.

  • On a quarterly basis, Times Interest Earned rose 97.67% to -$1.3 in Q4 2025 year-over-year; TTM through Dec 2025 was -$36.88, a 16.39% increase, with the full-year FY2025 number at -$36.88, up 16.39% from a year prior.
  • Times Interest Earned was -$1.3 for Q4 2025 at Myriad Genetics, up from -$6.13 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$1.3 in Q4 2025 to a low of -$227.4 in Q2 2023.
  • A 5-year average of -$61.47 and a median of -$50.67 in 2024 define the central range for Times Interest Earned.
  • Peak YoY movement for Times Interest Earned: tumbled 666.52% in 2023, then soared 97.67% in 2025.
  • Myriad Genetics' Times Interest Earned stood at -$86.2 in 2021, then skyrocketed by 32.71% to -$58.0 in 2022, then skyrocketed by 39.85% to -$34.89 in 2023, then crashed by 59.69% to -$55.71 in 2024, then skyrocketed by 97.67% to -$1.3 in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Times Interest Earned are -$1.3 (Q4 2025), -$6.13 (Q3 2025), and -$219.47 (Q2 2025).